Leadership Update
Leadership Update
PSC Support new co-leaders
We are pleased to share that Martine Walmsley and Mark Chatterley are now leading the charity. Together, they bring a wealth of experience and a shared commitment to our mission of improving the lives of everyone affected by PSC.
Martine has been a driving force within the PSC community for many years, most recently serving as Head of Research Strategy. Her deep understanding of the patient experience and her dedication to research advocacy have been instrumental in shaping our work. Mark joins her in this leadership role, bringing expertise that will help us build an organisation that can accelerate our progress toward better treatments and, ultimately, a cure.
Under their leadership, PSC Support will continue to focus on our core priorities: funding vital research, providing evidence-based information, and ensuring the patient voice is at the heart of everything we do.
Turning Ambition into Action in 2026:
Our Fortnight in Focus
At PSC Support, we want a world without PSC. We work tirelessly behind the scenes to drive research and improve lives. Here is a snapshot of what we've been up to:
Building Partnerships: We contributed a comprehensive chapter to a new medical textbook for nurses and allied health professionals, ensuring that the patient perspective is integrated into clinical education.
Building Partnerships: We participated in a planning meeting for the update of national clinical guidelines for PSC.
Building Partnerships: We prepared strategic questions for an upcoming international forum titled “Putting Patients First: From Research to Treatment.”
Organisational Excellence: We updated our web details to make it less likely information from us sent by email ends up in your spam folders.
Progressing Research: We are collaborating with European partners to develop a simplified research registry for pregnancy outcomes, building the evidence base needed to improve medical guidance for women with PSC.
Progressing Research: We completed a formal submission to the Scottish Medicines Consortium to advocate for the value of a potential new treatment for PSC patients.
Progressing Research: We reviewed the participant information for a new academic clinical trial to ensure it is clear and accessible for patients.